tirzepatide while pregnant and Pregnancy: Safety, Risks, and Clinical Guidance Can Tirzepatide Make Birth Control

Typical monitoring schedule includes: Baseline assessments: HbA1c, fasting glucose, renal function, liver function, lipid profile, blood pressure, weight, and BMI 3-month review: Assessment of tolerability, weight change, HbA1c (for diabetes), blood pressure, and any adverse effects 6-month review: Comprehensive reassessment including blood tests, weight trajectory, treatment goals achievement, and decision regarding continuation Ongoing reviews: Every 36 months once stable, with annual comprehensive assessments NICE guidance recommends that GLP-1 therapy for diabetes should be continued only if beneficial responses are demonstratedtypically defined as HbA1c reduction of at least 11 mmol/mol (1.0%) and weight loss of at least 3% of initial body weight at 6 months

That dual approval reflects the compound mechanism of action, which treats weight and metabolic health as interconnected problems rather than separate issues

Copper peptides help reduce oxidative stress by neutralising free radicals, which would otherwise damage skin cells and lead to inflammation and acne flare-ups

Should you experience persistent vomiting or severe diarrhoea, contact your GP promptly, as you may require assessment for dehydration